The U.S. government has said it is considering providing approximately 60 million doses of AstraZeneca's new coronavirus vaccine, which is manufactured domestically, to other countries with the consent of the regulator. ..
"We are considering options for distributing AstraZeneca's new coronavirus vaccine manufactured in the United States in the coming months," Saki, a spokesman for the White House, said at a press conference on the 26th. With the consent of the Food and Drug Administration, it said it was considering offering it to other countries.
The target is about 60 million times, including about 10 million times already manufactured and about 50 million times manufactured over June.
Saki said that while three types of vaccines are already being vaccinated in the United States, AstraZeneca's vaccine has not yet been approved for use. No, "he explained.
In the United States, all people over the age of 16 are eligible for vaccination, and by the 26th, 28.9% of the population has completed vaccination. The voice is getting stronger.
Saki spokesman said at a press conference last month that he was considering providing the vaccine to Mexico and Canada, but at the press conference on that day, he said, "There are requests from all over the world, and we will consider it in the future. I just said.